New diabetes clinical trial: CGMIS 48-hour Feasibility Study

Published on: September 30, 2022 at 09:30PM
Condition:   Type1diabetes
Intervention:   Device: CGMIS (Continuous Glucose Monitoring Infusion Set)
Sponsor:   Pacific Diabetes Technologies
Recruiting
https://ift.tt/3AB9qxr